The Implications of the Generics UK ‘Pay-for-Delay’ Ruling of the Court of Justice of the European Union. (C-307/18 Generics UK Ltd and Others v Competition and Market Authority of the 30th January 2020.)

On 20 January 2020, the Court of Justice of the European Union (CJEU) handed down its ruling in Case C-307/18 Generics (UK) and Others on ten complex questions referred by the UK Competition Appeal Tribunal (CAT) in the context of an appeal against a decision of the UK Competition and Markets Authority (CMA). In what will probably come to be regarded as a landmark judgment in EU competition law, the CJEU ruled for the first time on settlement agreements between originator pharmaceutical companies and producers of generic medicines